KO

KOMIPHARM INTERNATIONAL CO., LTD.

Develops animal health products and novel drugs for human cancer and autoimmune diseases.

041960 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 시흥시 경제로 17, 시흥시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Komipharm International Co., Ltd. is a biopharmaceutical company with core operations in animal health and a strategic focus on human therapeutics. The company develops, manufactures, and sells a diverse portfolio of veterinary products, including vaccines, pharmaceuticals, and disinfectants for livestock, poultry, and companion animals. Leveraging over 50 years of industry experience, Komipharm is also engaged in the research and development of novel drugs for human use. Its pharmaceutical pipeline concentrates on creating therapeutic agents for challenging indications such as cancer pain and autoimmune diseases, as part of its strategy to expand into the global bio-industry.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for KOMIPHARM INTERNATIONAL CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-15 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(약식)
Korean 122.0 KB

Automate Your Workflow. Get a real-time feed of all KOMIPHARM INTERNATIONAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for KOMIPHARM INTERNATIONAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Goodwill Pharma Plc Logo
Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.
Hungary GWPH
A biotech firm in biopharma, diagnostics, digital health, and consumer wellness products.
South Korea 005250
GREEN CROSS WellBeing Corporation Logo
Develops personalized nutrition solutions, from prescription injections to supplements & cosmetics.
South Korea 234690
Grifols S.A. Logo
Leading producer of plasma-derived medicines for patients with rare and chronic diseases.
Spain GRF
Grindeks Logo
Develops & manufactures pharmaceuticals for cardiovascular, CNS, cancer, and diabetes globally.
Latvia GRD1R
Guard Therapeutics International AB Logo
Clinical-stage biotech developing drugs to prevent acute kidney injury during open-heart surgery.
Sweden GUARD
Develops research antibodies and distributes scientific instruments for life science researchers.
South Korea 036180
Haleon PLC Logo
A global consumer healthcare leader providing trusted, science-backed OTC brands for everyday health.
United Kingdom HLN
Halychpharm Logo
A pharmaceutical manufacturer of finished medicines and plant-derived phytochemical substances.
Ukraine GFARM
HANALL BIOPHARMA CO.,LTD Logo
Develops innovative medicines for chronic diseases through antibody and small molecule research.
South Korea 009420

Talk to a Data Expert

Have a question? We'll get back to you promptly.